Jefferies has maintained its underperform rating on Navin Fluorine, projecting a 10.5% downside in share price from the current market price (CMP). Although the company’s recent earnings were weak, the commissioning of a new agrochemical plant in Q3 is expected to drive growth. Additionally, the commencement of two new contracts in the CDMO segment in Q4 should further accelerate the company’s growth trajectory.
Despite these upcoming catalysts, Jefferies has cut its FY25/26 PAT estimates by 9% and 8%, respectively, due to softer growth in the specialty chemicals segment. With the stock trading at 41x one-year forward PE, the risk-reward profile appears unfavorable.
Currently, Navin Fluorine’s stock is trading at ₹3,297.70.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Please consult with a qualified financial advisor before making any investment decisions.
